Kurma Partners is a European venture capital firm specializing in healthcare, biotechnology, and environmental science investments. The firm focuses on transforming disruptive scientific discoveries into cutting-edge medicines and medical devices, targeting severe diseases with high unmet medical needs. Kurma Partners has built a strong network with leading European academic research institutions to identify and develop innovative healthcare solutions.
The firm's unique approach involves working closely with top European research centers to build the healthcare industry of tomorrow. Notable portfolio companies include Armgo Pharma and Mila. Kurma Partners invests across various stages, including seed and Series B rounds, demonstrating their commitment to supporting companies throughout their growth journey. Their investment philosophy emphasizes high standards and a focus on creating impactful healthcare solutions.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
Top Investment Stages

Neo Kuma Ventures
neokuma.co
Sitka Partners

Bioqube Ventures

BioMedPartners
biomedvc.com

Panakes Partners

Vesalius Biocapital Partners

V-Bio Ventures
v-bio.ventures

Seventure Partners
seventure.fr

Columbus Venture Partners
columbusvp.com

Truffle Capital
truffle.com

Boutique Venture Partners
boutiquevc.com

i&i Biotech Fund
inibio.eu

Hikma Ventures
hikmaventures.com
Venture Partners
venturepartners.ch
Carevolution
carevolution.be

Karista
karista.vc

Kaya
kaya.vc

EMV Capital
emvcapital.com

Breega
breega.com

Karma Ventures
karma.vc

Coave Therapeutics

Kurma Partners: A European venture capital firm specializing in healthcare, biotechnology, and environmental science investments.